Oncology

MEN 2019: 16th International Workshop on Multiple Endocrine Neoplasia


MD Anderson Logo
Wednesday, March 27, 2019 | 5:30 p.m. Add to Calendar

Additional dates:
Event Calendar Icon Next Event: March 27, 2019 12:00 p.m.
Event Calendar Icon March 28, 2019
Event Calendar Icon March 29, 2019

Focus

In keeping with the spirit of the original MEN workshop, MEN2019 will focus on emerging topics in the genesis and therapy of malignant endocrine tumors associated with multiple endocrine neoplasia. The goal of the workshop will be to provide an outline for basic and clinical research focused on these malignant manifestations.  The meeting will bring together local and international experts on multiple endocrine neoplasia to focus on
these subjects.

A significant portion of the meeting will be spent in workshops centered on emerging topics and the development of an international roadmap for future research and clinical trials.

The remainder of the meeting will be composed of large group didactic sessions.  The University of Texas MD Anderson Cancer Center is a leader in the development of new therapies for cancer. Our goal is to combine the extensive local scientific and clinical talent at MD Anderson along with international experts to allow focus on emerging topics including new directions in immunotherapy, emerging concepts in the use of signaling pathway inhibitors, genetic diagnosis & therapy and new clinical advances that impact management of endocrine tumor syndromes.

A specific outcome of this conference will be a white paper summarizing the goals of this work.

Educational Objectives

After attending the conference, participants should be able to:

  • Identify and utilize alternative therapies to the traditional targeted therapy for the treatment of medullary thyroid cancer that may benefit their patients (Knowledge, Competence, Performance);
  • Gain an awareness of modern therapy for pancreatic neuroendocrine tumors so that the most efficacious therapy may be delivered (Knowledge, Competence, Performance, Patient Outcomes);
  • Utilize options to treat symptoms of excessive hormonal secretion in patients with malignant pheochromocytoma and paraganglioma (Knowledge, Competence, Performance);
  • Understand men in function and telomere biology in pancreatic neuroendocrine tumors (Knowledge);
  • Appreciate the clinical trials available for patients with parathyroid cancer and enroll them appropriately (Knowledge, Competence, Performance);
  • Understand basic, clinical, and translational genetics with regard to TP53 germ line (Knowledge).

Educational Methods

  • Lecture/Didactic
  • Poster Session
  • Interactive Groups/Breakouts

Evaluation

A conference evaluation link will be included in the final program.  This online survey will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations, as well as to identify future educational topics.

Links

 


Location

The University of Texas MD Anderson Cancer Center

1155 Pressler St.
Houston, Texas 77030

Contact

Allison Baring

713-563-7388